these findings suggest that , similar to what was recently reported in normal individuals and in laboratory animals , the probable mode of action of gemfibrozil is in reducing the secretion of atherogenic lipoproteins , particularly vldl , while stimulating the production of small hdl particles .
C0023820
lipoproteins
C0023825
vldl